Senior Director, Regulatory Affairs
For the last 17+ years, Jason McEwan has served as both a regulator and an advocate of the regulated innovative pharmaceutical industry, particularly in niche and specialty product areas (ie. radiopharmaceuticals, biosimilars, anti-infectives, etc.). He has significant experience in crisis management and was part of a team which was awarded the Ministers Award for Collaborative Leadership and Greatest Contribution to the Healthcare of Canadians.
Most recently, he has worked with a small company and the FDA to develop a product for the treatment and prevention of SARS-CoV-2 infections and been involved in preparations for an Emergency Use Authorization.